Eribulin Mesylate 60505-6435-00

Package NDC

60505-6435-00

Manufacturer: Apotex Corp.
Dosage Form: Injection
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: March 19, 2025
Listing Expires: December 31, 2026
Application: ANDA218047

Need to source Eribulin Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Eribulin Mesylate	.5 mg/mL

Drug Class

Microtubule Inhibition [PE]Microtubule Inhibitor [EPC]

Selected Package

60505-6435-00Selected

1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6435-0) / 2 mL in 1 VIAL, SINGLE-DOSE